Georges Gaudriault
Chief Tech/Sci/R&D Officer at DEINOVE
Georges Gaudriault active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DEINOVE | Chief Tech/Sci/R&D Officer | 22/05/2017 | - |
Career history of Georges Gaudriault
Former positions of Georges Gaudriault
| Companies | Position | Start | End |
|---|---|---|---|
Obe Therapy Biotechnology SAS
 Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - | - |
Obetherapy
 Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Chief Tech/Sci/R&D Officer | - | - |
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | - | - |
Training of Georges Gaudriault
| University of Nice Sophia Antipolis | Doctorate Degree |
Statistics
International
| France | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Private companies | 3 |
|---|---|
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Obe Therapy Biotechnology SAS
Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Health Services |
Obetherapy
Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Health Technology |
- Stock Market
- Insiders
- Georges Gaudriault
- Experience
